http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104211802-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21022 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 |
| filingDate | 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104211802-B |
| titleOfInvention | Human blood coagulation light chain protein and its application |
| abstract | The present invention has detected the minimum inhibitory concentration of the anti-different Gram-negative bacterias of human blood coagulation light chain protein by In Vitro Bacteriostatic, inhibiting effect of the human blood coagulation light chain protein to Gram-negative bacteria is had detected by internal bacteriostatic activity, it demonstrates human blood coagulation light chain protein to significantly inhibit Gram-negative bacteria, to develop the newtype drug of a kind for the treatment of gram positive bacterial infection.The hydrolysis and scavenging effect that human blood coagulation light chain protein induced by endotoxin is demonstrated by mass spectrum and silver staining detection, to develop the newtype drug of a kind for the treatment of endotoxemia.The human blood coagulation light chain protein be human blood coagulation factors VII, Ⅸ, Ⅹ light chain protein, and with they have 50% or more homology albumen. |
| priorityDate | 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.